Drawing for UT

USPTO serial 79350407

UT

Reviewed by CopyMark Law Group

Reg. 7256757Status 700Registered
Filing date
Status date
Registration date
Jan 2, 2024
Examiner
NOVAKOVIC, MIROSLAV
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Danielle I. Mattessich

Danielle I. Mattessich Merchant & Gould P.C.P.O. Box 2910Minneapolis, MN 55402-0910United States

Goods and services

ClassDescriptionStatusFirst use
009Bio manufacturing equipment for laboratory research, clinical research and trials and for biopharmaceutical manufacturing industries, namely, containment isolators for sterility purposes or to prevent contamination, cell culture vessels, bioreactors for cell culturing, bioreactors for laboratory use, cabinets in the nature of biological safety cabinets for cell cultures, cell culture instruments, namely, incubators for cell culture, equipment for purification of cell cultures and isolation of target molecules, equipment for analyzing cell cultures and target molecules, and equipment for analyzing cell cultures, target molecules and pharmaceutical preparations, equipment for packaging in the nature of incubating pharmaceutical preparations, laboratory centrifuges, filters, bottle top filters used for the purification of tissue culture media, laboratory fluidized bed reactors (fbr), storage vessels in the nature of cell culture dishes, filtration membranes and process control equipment in the nature of temperature controllers, concentration meters, control valves and level switches for monitoring, electrical sensors, oxygen sensors, biomass sensors, thermistors, temperature sensors, liquid level sensors, temperature indicators, ultrasonic sensors and ultrasonic flow detectors, controlling and regulating the flow of gases or liquids, all forming an integrated platform and for the viral vaccine production; replacement parts of the aforesaid goods; laboratory equipment for bioprocessing, namely, self-contained bio manufacturing chambers containing environmental control and containment barriers for use in safe handling of biological materials, also for use in manufacturing of biologics, none of which are for medical purposes; bioreactors for cell culturing; disposable plastic bioreactors for cell culturingACTIVE—
037Installation and maintenance of biopharmaceutical manufacturing equipment; advisory services relating to the installation and maintenance of biopharmaceutical manufacturing equipmentACTIVE—
042Engineering, scientific and technological consultancy on process, namely, product development relating to the manufacture of biologics; engineering, scientific and technological consultancy on production units for the development and production of biologics, namely, product development; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; biochemical engineering services; technical engineering in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; product and pharmaceutical research and development for the pharmaceutical and biotechnology industries; custom design and development of chemical reagents; analytical testing services, namely, materials evaluation testing of pharmaceutical, biopharmaceutical and chemical products, featuring testing for safety, toxicity, content, identity, purity, configuration and function; providing counseling and information with regard to aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 23, 2024FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 4, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 4, 2024FIMPFINAL DISPOSITION PROCESSED—
Apr 2, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 2, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 29, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 29, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 21, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 17, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 27, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2023RFNTREFUSAL PROCESSED BY IB—
Jun 7, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 7, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 12, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 11, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2023DOCKASSIGNED TO EXAMINER—
Sep 27, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 23, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance